Racial/ethnic differences in patient experiences with health care in association with earlier stage at breast cancer diagnosis: findings from the SEER-CAHPS data

Farias, Albert J.; Ochoa, Christian; Toledo, Gabriela; Bang, Soo-In; Hamilton, Ann S.; Du, Xianglin L.

doi:10.1007/s10552-019-01254-3

Cited by 26 publications

(46 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean age of diagnosis of breast carcinoma in the present study was 54.63 years. This contrasts with data from the US, where the mean age of diagnosis is 61 years [10]. Our results are more in line with the findings of Lara-Medina et al [9] and Rodriguez-Cuevas et al [11], where the mean age of diagnosis of breast carcinoma in Mexican women was 50 and 53.5 years, respectively.…”

Section: Discussionsupporting

confidence: 77%

Prevalence and Molecular Profile of Breast Carcinoma Using Immunohistochemistry Markers in Mexican Women

et al. 2021

View full text Add to dashboard Cite

Background: In Mexico, breast cancer is the leading cause of death by malignant tumors in women aged 20 and older. The World Health Organization estimates that 69% of deaths caused by breast cancer occur in developing countries. Little is known about the prevalence of breast carcinoma in Mexico and its molecular subclassification.Methods: This retrospective cross-sectional study included patients who underwent a mastectomy (single, radical or lumpectomy) or a breast tumor biopsy (core-needle or excisional) from January 2002 to December 2018. The primary purpose of the study was to determine the prevalence and molecular profile of breast in comprehensive cancer center in Mexico and compare our results with those published in the US. This study was approved by our scientific and bioethical committee. Results:The final analysis included 379 patients. The youngest patient was 23 years old and the oldest patient was 89; the mean age at diagnosis was 54.63 years. Patients of 40 years old or younger accounted for 48 of the cases (12.66%) and those older than 40 accounted for 331 of the cases (87.33%). The molecular subclassification showed luminal A subtype in 139 cases (36.67%), luminal B subtype in 143 cases (37.73%), human epidermal growth factor receptor 2-positive carcinomas in 32 cases (8.44%) and triple-negative carcinomas in 65 cases (17.15%). Diabetes mellitus was present in 43 patients (11.34%), hypertension in 78 patients (20.58%), obesity in 82 patients (21.63%) and 66 patients reported being treated with exogenous hormone therapy (17.41%). Conclusions:Breast carcinoma occurs at an earlier age in Mexican women compared to women in the US. Hormone-positive tumors were found to be more prevalent in older patients, while high-grade tumors were more frequently identified in younger patients.

show abstract

Section: Discussionsupporting

confidence: 77%

Prevalence and Molecular Profile of Breast Carcinoma Using Immunohistochemistry Markers in Mexican Women

et al. 2021

View full text Add to dashboard Cite

show abstract

“… 39 In terms of experience with cancer diagnosis, patients who were diagnosed with late stage disease were more likely to report worse care experiences in England, 40 and in the USA. 41 , 42 , 43 Moreover, patients with multiple myeloma and pancreatic cancer were more likely to report negative experiences in England, 19 , 44 while patients with thyroid, vulvar, and multiple myeloma cancers were more likely to report negative experiences in Australia. 45 In addition, patients with cancer of unknown primary in England were more likely to prefer more written information about their type of cancer and tests received compared to those with metastatic disease of known primary.…”

Section: Resultsmentioning

confidence: 99%

“…Men were more likely to avoid asking about cancer information than women. Farias et al., 2020 42 Racial/ethnic differences in patient experiences with health care in association with earlier stage at breast cancer diagnosis: findings from the SEER-CAHPS data Cross-sectional study using the SEER- CAHPS data for breast cancer patients who completed CAHPS survey between 1997 and 2011 To identify whether there is variation in patients’ experiences by their ethnicity and whether that is associated with stage at diagnosis. 1 Ethnic minorities reported poorer experiences with care preceding a diagnosis of breast cancer.…”

Section: Resultsmentioning

confidence: 99%

Factors influencing cancer patients’ experiences of care in the USA, United Kingdom, and Canada: A systematic review

et al. 2022

View full text Add to dashboard Cite

“…Racial inequities in time to treatment have been linked to racial disparities in mortality [14][15][16]. A number of factors have been identified as contributing to delays in care for Black breast cancer survivors, many of which are related more broadly to healthcare system barriers that limit access to care [17][18][19].…”

Section: Introductionmentioning

confidence: 99%

Differences in Emotional Distress Among Black and White Breast Cancer Survivors During the Covid-19 Pandemic: a National Survey

Hamlish

Papautsky

2021

J. Racial and Ethnic Health Disparities

View full text Add to dashboard Cite

The Covid-19 pandemic is straining US healthcare resources, causing significant disruptions in cancer care. Prior to the pandemic, Black cancer survivors experienced a disproportionate burden of delays in cancer treatment compared to White cancer survivors. As a result of the pandemic, disruptions in care are widespread and affect cancer survivors regardless of race. This shift presented an opportunity to investigate differences in how Black and White cancer survivors experience disruptions in cancer care due to the pandemic. We conducted a national survey of adult breast cancer survivors, distributed online from 4/2/20 to 4/27/20. We used t -tests to compare cancer and non-cancer-related worry during the Covid-19 pandemic between Black and White breast cancer survivors. Analysis of data from 570 respondents (106 Black and 464 White) indicated significantly higher levels of distress among White respondents compared to Black respondents. Our results point to the importance of assessing race differences in emotional response to disruptions in cancer care during the pandemic. We suggest that differences in emotional distress may reflect differences in previous experience of treatment delays and coping strategies between Black and White breast cancer survivors.

show abstract

Racial/ethnic differences in patient experiences with health care in association with earlier stage at breast cancer diagnosis: findings from the SEER-CAHPS data

Cited by 26 publications

References 37 publications

Prevalence and Molecular Profile of Breast Carcinoma Using Immunohistochemistry Markers in Mexican Women

Prevalence and Molecular Profile of Breast Carcinoma Using Immunohistochemistry Markers in Mexican Women

Factors influencing cancer patients’ experiences of care in the USA, United Kingdom, and Canada: A systematic review

Differences in Emotional Distress Among Black and White Breast Cancer Survivors During the Covid-19 Pandemic: a National Survey

Contact Info

Product

Resources

About